258 related articles for article (PubMed ID: 23787802)
1. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
Chouaid C; Agulnik J; Goker E; Herder GJ; Lester JF; Vansteenkiste J; Finnern HW; Lungershausen J; Eriksson J; Kim K; Mitchell PL
J Thorac Oncol; 2013 Aug; 8(8):997-1003. PubMed ID: 23787802
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S; Vaiani M; Lucioni C; Messori A
Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients surviving non-small cell lung cancer.
Grutters JP; Joore MA; Wiegman EM; Langendijk JA; de Ruysscher D; Hochstenbag M; Botterweck A; Lambin P; Pijls-Johannesma M
Thorax; 2010 Oct; 65(10):903-7. PubMed ID: 20861294
[TBL] [Abstract][Full Text] [Related]
4. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
Iyer S; Taylor-Stokes G; Roughley A
Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
6. Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis.
Sakthong P; Kasemsup V
Value Health; 2012; 15(1 Suppl):S79-84. PubMed ID: 22265072
[TBL] [Abstract][Full Text] [Related]
7. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
Wood R; Taylor-Stokes G; Smith F; Chaib C
Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
[TBL] [Abstract][Full Text] [Related]
8. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey.
Moradi M; Rencz F; Brodszky V; Moradi A; Balogh O; Gulácsi L
Arch Iran Med; 2015 Mar; 18(3):153-9. PubMed ID: 25773688
[TBL] [Abstract][Full Text] [Related]
9. Health state utility scores in advanced non-small cell lung cancer.
Doyle S; Lloyd A; Walker M
Lung Cancer; 2008 Dec; 62(3):374-80. PubMed ID: 18467000
[TBL] [Abstract][Full Text] [Related]
10. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057.
Reck M; Brahmer J; Bennett B; Taylor F; Penrod JR; DeRosa M; Dastani H; Spigel DR; Gralla RJ
Eur J Cancer; 2018 Oct; 102():23-30. PubMed ID: 30103096
[TBL] [Abstract][Full Text] [Related]
12. Health state utilities in patients with advanced non-small-cell lung cancer in China.
Shen Y; Wu B; Wang X; Zhu J
J Comp Eff Res; 2018 May; 7(5):443-452. PubMed ID: 29775084
[TBL] [Abstract][Full Text] [Related]
13. Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer: Results from the CheckMate 017 Study.
Reck M; Taylor F; Penrod JR; DeRosa M; Morrissey L; Dastani H; Orsini L; Gralla RJ
J Thorac Oncol; 2018 Feb; 13(2):194-204. PubMed ID: 29129758
[TBL] [Abstract][Full Text] [Related]
14. Does caring for patients with advanced non-small cell lung cancer affect health-related quality of life of caregivers? A multicenter, cross-sectional study.
Yang Y; Liu L; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Chen Y
BMC Public Health; 2024 Jan; 24(1):224. PubMed ID: 38238722
[TBL] [Abstract][Full Text] [Related]
15. The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy.
Ramaekers BL; Joore MA; Grutters JP; van den Ende P; Jong Jd; Houben R; Lambin P; Christianen M; Beetz I; Pijls-Johannesma M; Langendijk JA
Oral Oncol; 2011 Aug; 47(8):768-74. PubMed ID: 21683647
[TBL] [Abstract][Full Text] [Related]
16. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
[TBL] [Abstract][Full Text] [Related]
17. Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.
Jang RW; Isogai PK; Mittmann N; Bradbury PA; Shepherd FA; Feld R; Leighl NB
J Thorac Oncol; 2010 Dec; 5(12):1953-7. PubMed ID: 21155140
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
19. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
[TBL] [Abstract][Full Text] [Related]
20. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
Carreño A; Fernández I; Badia X; Varela C; Roset M
Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]